Director/PDMR Shareholding

RNS Number : 5610L

Hikma Pharmaceuticals Plc

06 September 2019

 

Notification and public disclosure of transactions by person discharging managerial responsibilities

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Said Darwazah
2	Reason for the notification
a)	Position/status	Executive Chairman
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083
b)	Nature of the transaction	Disposal of 150,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC by Banque Lombard Odier & Cie SA
c)	Price(s) and volume(s)	Price(s): £20.56 Volume(s): 49,826 Price(s): £19.85 Volume(s): 25,000 Price(s): £19.82 Volume(s): 25,000 Price(s): £19.84 Volume(s): 25,000 Price(s): £19.82 Volume(s): 25,174
d)	Aggregated information	Aggregated volume: 150,000 Price: £20.07 Total: £3,011,121
e)	Date of the transaction	4 and 6 September 2019
f)	Place of the transaction	London Stock Exchange (XLON)

Peter Speirs, Company Secretary, Responsible for releasing this announcement

6 September 2019

 

END

 

 

DSHBSGDCXDGBGCL